These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1756491)

  • 41. Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia.
    Sawyers CL
    Leuk Lymphoma; 1993; 11 Suppl 2():101-3. PubMed ID: 8124222
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Further evidence of the involvement of the c-abl oncogene in chronic myelogenous leukemia and acute lymphocytic leukemia.
    Szabo P; Macera MJ; Verma RS
    Mol Biol Med; 1988 Dec; 5(3):139-44. PubMed ID: 3072467
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New approach in the diagnosis and monitoring of treatment in chronic myelogenous leukemia].
    Matolcsy A
    Orv Hetil; 2004 Dec; 145(52):2603-9. PubMed ID: 15724695
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
    Laneuville P; Sullivan AK
    Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome.
    Zagaria A; Anelli L; Albano F; Storlazzi CT; Liso A; Roberti MG; Buquicchio C; Liso V; Rocchi M; Specchia G
    Cancer Genet Cytogenet; 2004 Apr; 150(1):81-5. PubMed ID: 15041230
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11.2) translocation in a patient with a clinically typical chronic myeloid leukemia.
    Griesinger F; Hennig H; Hillmer F; Podleschny M; Steffens R; Pies A; Wörmann B; Haase D; Bohlander SK
    Genes Chromosomes Cancer; 2005 Nov; 44(3):329-33. PubMed ID: 16001431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Molecular genetics of the pathogenesis and classification of chronic myelocytic leukemia].
    Bartram CR
    Onkologie; 1987 Jun; 10(3):127-32. PubMed ID: 3306531
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular differentiation of two different translocations producing two apparent Ph chromosomes in a patient with CML.
    Gonsebatt ME; Lisker R; Mutchinick O; Ruz L; Cortez J; Labardini J; Schraven KD; Pearce-Birge L
    Cancer Genet Cytogenet; 1991 Jul; 54(2):247-52. PubMed ID: 1884359
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The molecular biology of chronic myeloid leukaemia.
    Melo JV
    Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. No evidence for genomic imprinting of the human BCR gene.
    Fioretos T; Heisterkamp N; Groffen J
    Blood; 1994 Jun; 83(12):3441-4. PubMed ID: 8204871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chromosomal breakpoints within the first intron of the ABL gene are nonrandom in patients with chronic myelogenous leukemia.
    Jiang XY; Trujillo JM; Liang JC
    Blood; 1990 Aug; 76(3):597-601. PubMed ID: 2198962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
    Randolph TR
    Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Standpoint on imprinting of BCR and ABL.
    Fioretos T; Heisterkamp N; Groffen J
    Leukemia; 1995 Apr; 9(4):743-4. PubMed ID: 7723414
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR/ABL and p210BCR/ABL to the phosphatidylinositol-3' kinase pathway.
    Sattler M; Salgia R; Okuda K; Uemura N; Durstin MA; Pisick E; Xu G; Li JL; Prasad KV; Griffin JD
    Oncogene; 1996 Feb; 12(4):839-46. PubMed ID: 8632906
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cancer genetics. Imprinting in leukaemia.
    Reik W
    Nature; 1992 Oct; 359(6394):362-3. PubMed ID: 1406944
    [No Abstract]   [Full Text] [Related]  

  • 56. Review of clinical, cytogenetic, and molecular aspects of Ph-negative CML.
    van der Plas DC; Grosveld G; Hagemeijer A
    Cancer Genet Cytogenet; 1991 Apr; 52(2):143-56. PubMed ID: 2021916
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
    Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
    Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Subcellular localization of Bcr, Abl, and Bcr-Abl proteins in normal and leukemic cells and correlation of expression with myeloid differentiation.
    Wetzler M; Talpaz M; Van Etten RA; Hirsh-Ginsberg C; Beran M; Kurzrock R
    J Clin Invest; 1993 Oct; 92(4):1925-39. PubMed ID: 8408645
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Localisation and distance between ABL and BCR genes in interphase nuclei of bone marrow cells of control donors and patients with chronic myeloid leukaemia.
    Lukásová E; Kozubek S; Kozubek M; Kjeronská J; Rýznar L; Horáková J; Krahulcová E; Horneck G
    Hum Genet; 1997 Oct; 100(5-6):525-35. PubMed ID: 9341866
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical evaluation of a DNA probe assay for the Philadelphia (Ph1) translocation in chronic myelogenous leukemia.
    Blennerhassett GT; Furth ME; Anderson A; Burns JP; Chaganti RS; Blick M; Talpaz M; Dev VG; Chan LC; Wiedemann LM
    Leukemia; 1988 Oct; 2(10):648-57. PubMed ID: 3050293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.